Serum insulin-like growth factor binding protein 2 is associated with hepatic steatosis in adults with metabolic dysfunction-associated steatotic liver disease
In patients with MASLD, IGFBP2 may exert a protective effect against hepatic steatosis progression but appears to play a negligible role in fibrogenesis.
Authors
- Lixuan Shen
- Wenbin Shang (ORCID: https://orcid.org/0000-0002-0317-5928)
- Xizhong Yu
- Yingying Xue (ORCID: https://orcid.org/0009-0008-5879-8955)
- Ziwei Zhu (ORCID: https://orcid.org/0000-0001-6423-9553)
- Hongyan Wu (ORCID: https://orcid.org/0000-0002-0184-2360)
- H Fu (ORCID: https://orcid.org/0000-0002-5058-8872)
- Jingyu Zhu (ORCID: https://orcid.org/0009-0004-2588-484X)
- Ziwei Wang (ORCID: https://orcid.org/0009-0003-8050-9121)
- Ruonan Zhou
Institutions
- Nanjing University of Chinese Medicine (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Endocrine Connections
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1530/ec-25-0285
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00